Hogg D - Search Results

1

Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas.

Shahnavaz SA, Bradley G, Regezi JA, Thakker N, Gao L, Hogg D, Jordan RC. Shahnavaz SA, et al. Among authors: hogg d. Cancer Res. 2001 Mar 15;61(6):2371-5. Cancer Res. 2001. PMID: 11289098

2

Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.

Gao L, Liu L, van Meyel D, Cairncross G, Forsyth P, Kimmel D, Jenkins RB, Lassam NJ, Hogg D. Gao L, et al. Among authors: hogg d. Clin Cancer Res. 1997 Jun;3(6):977-81. Clin Cancer Res. 1997. PMID: 9815774

3

Absence of the L37P polymorphism in exon 1 of the CDKN2A gene.

Fung JJ, Liu L, Gao L, Monzon J, Lassam NJ, Hogg D. Fung JJ, et al. Among authors: hogg d. Mol Cell Probes. 1997 Jun;11(3):231-2. doi: 10.1006/mcpr.1997.0098. Mol Cell Probes. 1997. PMID: 9232623 No abstract available.

4

Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma.

Liu L, Dilworth D, Gao L, Monzon J, Summers A, Lassam N, Hogg D. Liu L, et al. Among authors: hogg d. Nat Genet. 1999 Jan;21(1):128-32. doi: 10.1038/5082. Nat Genet. 1999. PMID: 9916806

5

Mutations of the p53 gene do not occur in testis cancer.

Peng HQ, Hogg D, Malkin D, Bailey D, Gallie BL, Bulbul M, Jewett M, Buchanan J, Goss PE. Peng HQ, et al. Among authors: hogg d. Cancer Res. 1993 Aug 1;53(15):3574-8. Cancer Res. 1993. PMID: 8339263

6

Loss of heterozygosity of tumor suppressor genes in testis cancer.

Peng HQ, Bailey D, Bronson D, Goss PE, Hogg D. Peng HQ, et al. Among authors: hogg d. Cancer Res. 1995 Jul 1;55(13):2871-5. Cancer Res. 1995. PMID: 7796415

7

Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.

Lal G, Liu L, Hogg D, Lassam NJ, Redston MS, Gallinger S. Lal G, et al. Among authors: hogg d. Genes Chromosomes Cancer. 2000 Apr;27(4):358-61. Genes Chromosomes Cancer. 2000. PMID: 10719365

8

Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF.

Liu L, Goldstein AM, Tucker MA, Brill H, Gruis NA, Hogg D, Lassam NJ. Liu L, et al. Among authors: hogg d. Genes Chromosomes Cancer. 1997 May;19(1):52-4. Genes Chromosomes Cancer. 1997. PMID: 9135995

9

CDKN2A mutation in a non-FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein.

Sun S, Pollock PM, Liu L, Karimi S, Jothy S, Milner BJ, Renwick A, Lassam NJ, Hayward NK, Hogg D, Narod SA, Foulkes WD. Sun S, et al. Among authors: hogg d. Int J Cancer. 1997 Nov 14;73(4):531-6. doi: 10.1002/(sici)1097-0215(19971114)73:4<531::aid-ijc13>3.0.co;2-c. Int J Cancer. 1997. PMID: 9389568

10

Germline CDKN2A mutation implicated in predisposition to multiple myeloma.

Dilworth D, Liu L, Stewart AK, Berenson JR, Lassam N, Hogg D. Dilworth D, et al. Among authors: hogg d. Blood. 2000 Mar 1;95(5):1869-71. Blood. 2000. PMID: 10688850 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters